Company Filing History:
Years Active: 2011-2013
Title: Vera Selitser: Innovator in Pharmaceutical Development
Introduction
Vera Selitser is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceutical development, particularly in the areas of drug repurposing and optimization of drug trials. With a total of 2 patents, her work is paving the way for innovative approaches in medicine.
Latest Patents
Vera's latest patents include techniques for purposing a new compound and for re-purposing a drug. One of her notable inventions is a method for repurposing a pharmaceutical compound. This method involves identifying a pharmaceutical compound that corresponds to a drug that has either failed in clinical development or is an approved drug. A mathematical model is created to describe the physiological processes related to at least one disease and the effects of the pharmaceutical compound on that disease. The model is adjusted based on information from preclinical or clinical trials, leading to a suggested treatment protocol that can salvage the failed drug or provide a new way to use an approved drug. Additionally, systems and computer program products encompassing these techniques are disclosed.
Another significant patent is an interactive technique for optimizing drug development from the pre-clinical phases through phase IV. This method involves performing interactive clinical trials for testing a new drug. A computer model for pharmacokinetics and pharmacodynamics of the drug is created and adjusted based on in vitro and in vivo studies. The process includes phase I clinical research, where a clinical trial is performed in parallel with computer simulation studies. This leads to the determination of an optimal protocol for the most responsive patient populations and indications for phase II clinical trials, followed by phase III and IV studies for long-term safety assessment.
Career Highlights
Vera Selitser is currently associated with Optimata Ltd., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a strong focus on improving drug development processes and enhancing the efficacy of existing medications.
Collaborations
Some of her notable coworkers include Levon Arakelyan and Zvia Agur, who contribute to her research and development efforts.
Conclusion
Vera Selitser's contributions to pharmaceutical innovation are noteworthy, as she continues to develop methods that enhance drug efficacy and safety. Her patents reflect a commitment to advancing medical science and improving patient outcomes.